• letlifehappen's Avatar

    letlifehappen posted a blog post

    By: European Organisation for Research and Treatment of Cancer From: medicalxpress.com Final analysis of results from a randomised clinical trial of lapatinib and trastuzumab given before surgery in patients with early HER2-positive breast cancer has found that women who had no signs of residual disease after treatment (known as a pathological complete response, pCR) survived longer without the cancer returning ...
    The post HER2+ breast cancer patients live longer if drugs given before surgery eradicate tumour appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    “Thinking about skipping your mammogram this year? Think again,” said Debi Olson. In January, Dr. Minh Nguyen, a breast-specialized radiologist at Solis Mammography, diagnosed two fast-growing, malignant breast cancers, one the size of a large bar of soap, in Debi’s right breast. Debi had only skipped one mammogram. She now shares her personal story to urge other women not to wait, ...
    The post Breast Cancer Doesn’t Quarantine, Radiologists Urge Women to Resume Screenings appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Natera, Inc. From: prnewswire.com Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA, today announced that its Signatera molecular residual disease (MRD) test will be used in the DARE study, a multi-center clinical trial of palbociclib (IBRANCE®), a CDK4/6 inhibitor developed by Pfizer for the treatment of HR-positive, HER2-negative advanced breast cancer when given in combination with ...
    The post Natera Announces Prospective Randomized Clinical Trial to Evaluate Palbociclib in Early Stage Breast Cancer Patients Who Test Positive with Signatera™ appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Thomas Jefferson University From: medicalxpress.com Breast cancer is one of the most common cancers among women in the U.S. It’s also the most costly cancer to treat. Now, Jefferson researchers have shown that although the use of an effective and less expensive treatment is on the rise, some patients, specifically Black women and those without private insurance are offered ...
    The post Not all patients are offered the same effective breast cancer treatment appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Discovery Life Sciences From: PR Newswire Discovery Life Sciences™ (Discovery) announces the launch of a powerful new tool for liquid biopsy diagnostic assay and oncology drug developers: SpecimenSeq™. SpecimenSeq is a collection of high quality, fully consented biospecimens that include clinical and molecular characterizations to help researchers identify, develop and validate new biomarker signatures for precision medicine applications. SpecimenSeq ...
    The post Discovery Life Sciences Launches SpecimenSeq™: Genomically and Clinically Annotated Biospecimen Sets to Speed Liquid Biopsy and Immunotherapy Development appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Metro Creative From: albanyherald.com Breast cancer is one of the most common forms of cancer diagnosed among the female population. Though breast cancer may seem like a disease that’s exclusive to women, breast cancer can affect men as well. While they have a smaller concentration than women, men have breast tissue, which means it’s possible for them to develop ...
    The post Symptoms of male breast cancer appeared first on Let Life Happen.